WSJ Minute Briefing - Bitcoin Hits New Intraday Record, Passing Inauguration Day High

Plus: Lowe’s shares drop as the company maintains its outlook and discloses lower sales. Google shares rebound from yesterday’s dip fueled by concerns about AI. T.J. Maxx’s earnings outlook misses expectations due to tariff-affected merchandise. Ariana Aspuru hosts.

 

Sign up for the WSJ's free What's News newsletter

Learn more about your ad choices. Visit megaphone.fm/adchoices

WSJ Minute Briefing - Target Sales Hit by DEI Boycott

Plus: Nvidia CEO Huang says U.S. export controls on advanced chips to China have failed. And Crusoe’s Texas data center for OpenAI secures $11.6 billion in funding to expand from two to eight buildings. Alex Ossola hosts. 


Boycotting Target: A WSJ Podcast Series 


Sign up for the WSJ's free What's News newsletter

Learn more about your ad choices. Visit megaphone.fm/adchoices

WSJ Minute Briefing - Republicans Near Agreement on State and Local Tax Deduction

Plus: Ford is to let rival Nissan use part of its flagship U.S. battery plant, as electric vehicle demand slows. And a new report by the International Energy Agency finds China continues to dominate the global supply of critical minerals. Kate Bullivant hosts.


Sign up for WSJ’s free What’s News newsletter

Learn more about your ad choices. Visit megaphone.fm/adchoices

WSJ Minute Briefing - U.S. Stocks Fall as Big Tech Companies Weigh on Major Indexes

Four out of the Magnificent Seven tech stocks fell today. Plus: Home Depot shares tick down despite quarterly sales rising more than expected. And shares of Arc’teryx and Salomon parent Amer Sports surge after strong quarterly results and raised guidance. Danny Lewis hosts.


Sign up for the WSJ's free What's News newsletter.

Learn more about your ad choices. Visit megaphone.fm/adchoices

WSJ Minute Briefing - Divided GOP Look to Vote on Tax Bill Midweek

Plus: Construction on a big wind project off New York’s coast is back on, after an abrupt about-face by the Trump administration. And Biotech firm Regeneron has agreed to buy 23andMe out of bankruptcy for $256 million dollars. Kate Bullivant hosts.


Sign up for WSJ’s free What’s News newsletter. 

Learn more about your ad choices. Visit megaphone.fm/adchoices